Characterisation of and risk factors for extended-spectrum β-lactamase producing Enterobacterales (ESBL-E) in an equine hospital with a special reference to an outbreak caused by Klebsiella pneumoniae ST307:CTX-M-1

被引:5
作者
Thomson, Katariina [1 ]
Eskola, Katarina [1 ]
Eklund, Marjut [1 ]
Suominen, Kristiina [2 ]
Maatta, Merita [1 ]
Junnila, Jouni [3 ]
Nykasenoja, Suvi [4 ]
Niinisto, Kati [5 ]
Gronthal, Thomas [1 ,4 ]
Rantala, Merja [1 ]
机构
[1] Univ Helsinki, Fac Vet Med, Dept Equine & Small Anim Med, POB 57, Helsinki 00014, Finland
[2] Univ Helsinki, Fac Vet Med, Dept Vet Biosci, POB 66, Helsinki 00014, Finland
[3] Oy 4Pharma Ltd, Arkadiankatu 7, Helsinki 00100, Finland
[4] Finnish Food Author, POB 100, Helsinki 00027, Finland
[5] Univ Helsinki, Vet Teaching Hosp, Fac Vet Med, POB 57, Helsinki 00014, Finland
关键词
Bacterial infection; Cluster; Horse; Multi-drug resistant bacteria; Nosocomial infection; Surveillance; ESCHERICHIA-COLI; ANTIMICROBIAL RESISTANCE; RECTAL COLONIZATION; INFECTIONS; HORSES; DISSEMINATION; ACQUISITION; SAMPLES;
D O I
10.1186/s13028-022-00621-6
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Background Extended-spectrum beta-lactamase producing Enterobacterales (ESBL-E) are important causative agents for infections in humans and animals. At the Equine Veterinary Teaching Hospital of the University of Helsinki, the first infections caused by ESBL-E were observed at the end of 2011 leading to enhanced infection surveillance. Contact patients were screened for ESBL-E by culturing infection sites and rectal screening. This study was focused on describing the epidemiology and microbiological characteristics of ESBL-E from equine patients of the EVTH during 2011-2014, and analysing putative risk factors for being positive for ESBL-E during an outbreak of Klebsiella pneumoniae ST307. Results The number of ESBL-E isolations increased through 2012-2013 culminating in an outbreak of multi-drug resistant K. pneumoniae ST307:bla(CTX-M-1):bla(TEM):bla(SHV) during 04-08/2013. During 10/2011-05/2014, altogether 139 ESBL-E isolates were found from 96 horses. Of these, 26 were from infection-site specimens and 113 from rectal-screening swabs. A total of 118 ESBL-E isolates from horses were available for further study, the most numerous being K. pneumoniae (n = 44), Escherichia coli (n = 31) and Enterobacter cloacae (n = 31). Hospital environmental specimens (N = 47) yielded six isolates of ESBL-E. Two identical E. cloacae isolates originating from an operating theatre and a recovery room had identical or highly similar PFGE fingerprint profiles as five horse isolates. In the multivariable analysis, mare-foal pairs (OR 4.71, 95% CI 1.57-14.19, P = 0.006), length of hospitalisation (OR 1.62, 95% CI 1.28-2.06, P < 0.001) and passing of a nasogastric tube (OR 2.86, 95% CI 1.03-7.95, P = 0.044) were associated with being positive for ESBL-E during the K. pneumoniae outbreak. Conclusions The occurrence of an outbreak caused by a pathogenic ESBL-producing K. pneumoniae ST307 strain highlights the importance of epidemiological surveillance of ESBL-E in veterinary hospitals. Limiting the length of hospitalisation for equine patients may reduce the risk of spread of ESBL-E. It is also important to acknowledge the importance of nasogastric tubing as a potential source of acquiring ESBL-E. As ESBL-E were also found in stomach drench pumps used with nasogastric tubes, veterinary practices should pay close attention to appropriate equipment cleaning procedures and disinfection practices.
引用
收藏
页数:14
相关论文
共 57 条
  • [1] Antimicrobial-resistant Enterobacteriaceae recovered from companion animal and livestock environments
    Adams, R. J.
    Kim, S. S.
    Mollenkopf, D. F.
    Mathys, D. A.
    Schuenemann, G. M.
    Daniels, J. B.
    Wittum, T. E.
    [J]. ZOONOSES AND PUBLIC HEALTH, 2018, 65 (05) : 519 - 527
  • [2] Antimicrobial resistance in equine faecal Escherichia coli isolates from North West England
    Ahmed, Mohamed O.
    Clegg, Peter D.
    Williams, Nicola J.
    Baptiste, Keith E.
    Bennett, Malcolm
    [J]. ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS, 2010, 9
  • [3] Occurrence and molecular characteristics of ESBL/AmpC-producing Escherichia coli in faecal samples from horses in an equine clinic
    Apostolakos, Ilias
    Franz, Eelco
    van Hoek, Angela H. A. M.
    Florijn, Alice
    Veenman, Christiaan
    Sloet-van Oldruitenborgh-Oosterbaan, Marianne M.
    Dierikx, Cindy
    van Duijkeren, Engeline
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2017, 72 (07) : 1915 - 1921
  • [4] Successful control of an extended-spectrum beta-lactamase-producing Klebsiella pneumoniae ST307 outbreak in a neonatal intensive care unit
    Baek, Eun-Hwa
    Kim, Se-Eun
    Kim, Sunjoo
    Lee, Seungjun
    Cho, Oh-Hyun
    Hong, Sun In
    Shin, Jeong Hwan
    Hwang, Inyeong
    [J]. BMC INFECTIOUS DISEASES, 2020, 20 (01)
  • [5] A case-control study of risk factors associated with rectal colonization of extended-spectrum beta-lactamase producing Klebsiella sp in newborn infants
    Boo, NY
    Ng, SF
    Lim, VKE
    [J]. JOURNAL OF HOSPITAL INFECTION, 2005, 61 (01) : 68 - 74
  • [6] Extended-spectrum β-lactamases in the 21st century:: Characterization, epidemiology, and detection of this important resistance threat
    Bradford, PA
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 2001, 14 (04) : 933 - 951
  • [7] Two high-risk clones of carbapenemase-producing Klebsiella pneumoniae that cause infections in pets and are present in the environment of a veterinary referral hospital
    Brilhante, Michael
    Brawand, Stefanie Gobeli
    Endimiani, Andrea
    Rohrbach, Helene
    Kittl, Sonja
    Willi, Barbara
    Schuller, Simone
    Perreten, Vincent
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2021, 76 (05) : 1140 - 1149
  • [8] Virulent Clones of Klebsiella pneumoniae: Identification and Evolutionary Scenario Based on Genomic and Phenotypic Characterization
    Brisse, Sylvain
    Fevre, Cindy
    Passet, Virginie
    Issenhuth-Jeanjean, Sylvie
    Tournebize, Regis
    Diancourt, Laure
    Grimont, Patrick
    [J]. PLOS ONE, 2009, 4 (03):
  • [9] Broberg Christopher A, 2014, F1000Prime Rep, V6, P64, DOI 10.12703/P6-64
  • [10] CDC, 2017, PNL06